Hunan Fangsheng Pharmaceutical Future Growth
Future criteria checks 2/6
Hunan Fangsheng Pharmaceutical is forecast to grow earnings and revenue by 16.5% and 15.5% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 17% in 3 years.
Key information
16.5%
Earnings growth rate
16.1%
EPS growth rate
| Pharmaceuticals earnings growth | 18.8% |
| Revenue growth rate | 15.5% |
| Future return on equity | 17.0% |
| Analyst coverage | Low |
| Last updated | 31 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Hunan Fangsheng Pharmaceutical's (SHSE:603998) Earnings Are Weaker Than They Seem
Nov 04
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet
Jun 06Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders
Apr 30Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,478 | 369 | N/A | 513 | 4 |
| 12/31/2025 | 2,144 | 299 | N/A | 328 | 4 |
| 12/31/2024 | 1,834 | 243 | N/A | 308 | 4 |
| 9/30/2024 | 1,762 | 273 | 104 | 216 | N/A |
| 6/30/2024 | 1,684 | 217 | 39 | 209 | N/A |
| 3/31/2024 | 1,630 | 193 | -7 | 198 | N/A |
| 12/31/2023 | 1,629 | 187 | -131 | 88 | N/A |
| 9/30/2023 | 1,649 | 168 | -67 | 163 | N/A |
| 6/30/2023 | 1,774 | 329 | -25 | 171 | N/A |
| 3/31/2023 | 1,806 | 315 | 12 | 198 | N/A |
| 12/31/2022 | 1,792 | 286 | 130 | 302 | N/A |
| 9/30/2022 | 1,812 | 267 | 88 | 279 | N/A |
| 6/30/2022 | 1,710 | 91 | 48 | 244 | N/A |
| 3/31/2022 | 1,653 | 81 | 31 | 218 | N/A |
| 12/31/2021 | 1,567 | 70 | 1 | 186 | N/A |
| 9/30/2021 | 1,466 | 66 | -55 | 125 | N/A |
| 6/30/2021 | 1,425 | 68 | -2 | 191 | N/A |
| 3/31/2021 | 1,351 | 68 | 57 | 235 | N/A |
| 12/31/2020 | 1,279 | 64 | 69 | 237 | N/A |
| 9/30/2020 | 1,199 | 69 | 45 | 196 | N/A |
| 6/30/2020 | 1,134 | 63 | -10 | 128 | N/A |
| 3/31/2020 | 1,119 | 75 | -28 | 149 | N/A |
| 12/31/2019 | 1,094 | 79 | -37 | 163 | N/A |
| 9/30/2019 | 1,073 | 83 | -29 | 150 | N/A |
| 6/30/2019 | 1,078 | 81 | 45 | 195 | N/A |
| 3/31/2019 | 1,041 | 74 | 55 | 154 | N/A |
| 12/31/2018 | 1,051 | 73 | 101 | 176 | N/A |
| 9/30/2018 | 1,000 | 45 | 134 | 187 | N/A |
| 6/30/2018 | 919 | 60 | N/A | 116 | N/A |
| 3/31/2018 | 837 | 65 | N/A | 65 | N/A |
| 12/31/2017 | 721 | 60 | N/A | 17 | N/A |
| 9/30/2017 | 706 | 88 | N/A | 46 | N/A |
| 6/30/2017 | 634 | 78 | N/A | 79 | N/A |
| 3/31/2017 | 567 | 72 | N/A | 111 | N/A |
| 12/31/2016 | 534 | 70 | N/A | 119 | N/A |
| 9/30/2016 | 470 | 75 | N/A | 86 | N/A |
| 6/30/2016 | 457 | 81 | N/A | 76 | N/A |
| 3/31/2016 | 464 | 86 | N/A | 87 | N/A |
| 12/31/2015 | 469 | 91 | N/A | 91 | N/A |
| 9/30/2015 | 460 | 91 | N/A | 85 | N/A |
| 6/30/2015 | 445 | 86 | N/A | 99 | N/A |
| 3/31/2015 | 446 | 89 | N/A | 129 | N/A |
| 12/31/2014 | 416 | 81 | N/A | 94 | N/A |
| 12/31/2013 | 400 | 73 | N/A | 123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603998's forecast earnings growth (16.5% per year) is above the savings rate (2.8%).
Earnings vs Market: 603998's earnings (16.5% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 603998's earnings are forecast to grow, but not significantly.
Revenue vs Market: 603998's revenue (15.5% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 603998's revenue (15.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603998's Return on Equity is forecast to be low in 3 years time (17%).